Microbiome, antibiotics and irritable bowel syndrome.

@article{Ahmad2016MicrobiomeAA,
  title={Microbiome, antibiotics and irritable bowel syndrome.},
  author={Omer F. Ahmad and Ayesha Akbar},
  journal={British medical bulletin},
  year={2016},
  volume={120 1},
  pages={
          91-99
        }
}
INTRODUCTION Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal (GI) disorder. Increasing evidence implicates the GI microbiota in IBS pathogenesis and its modulation represents an emerging therapeutic strategy. SOURCES OF DATA Original and review articles were identified through selective searches performed on PubMed and Google Scholar. AREAS OF AGREEMENT The role of gut microbiota in IBS is supported by evidence from animal and human studies. Randomized… Expand
Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
TLDR
The available data are promising, but presently, a precise definition of which probiotic or which mixture of probiotics is effective cannot be made and the dose and duration of treatment has not been established. Expand
Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome
TLDR
It is concluded that FMT induces long-term changes in gut microbiota, and these changes mirror the clinical effect of the treatment. Expand
A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome in Mice by Improving Gut Microbiota and Modulating Immune Response
TLDR
The results showed that PB significantly decreased the pro-inflammatory cytokines both in infected Caco-2 cells and PI-IBS models, and the loss of body weight, decreased expression of tight junction protein Occludin (OCLN), and changes of the microbiota composition induced by infections could be greatly improved by PB intervention. Expand
Successful Fecal Microbiota Transplantation in a Patient Suffering From Irritable Bowel Syndrome and Recurrent Urinary Tract Infections.
TLDR
IBS symptoms and UTI frequency decreased after FMT UTI, and further studies involving more patients would be relevant to confirm this work and develop bacteriotherapy. Expand
Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review
TLDR
There is evidence that antibiotics commonly used in primary care influence the composition of the gastrointestinal microbiota, and larger population-based studies are needed to fully understand how antibiotics modulate the microbiota and if these are associated with (longer term) health consequences. Expand
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
BACKGROUND Irritable bowel syndrome (IBS) is a common condition characterised by abdominal pain, bloating, and poor quality of life. IBS might be caused by a gut dysbiosis. We aimed to compare faecalExpand
Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review
TLDR
It is moderately confident that antibiotic treatment leads to antibiotic resistance development in neonates and it may also induce potentially disease-promoting gut microbiota alterations, and the need to reduce unnecessary antibiotic treatment in Neonates is emphasized. Expand
Mining Human Microbiome for Therapeutics
TLDR
This chapter gives insights into the history, development, and the current scenario of the use of probiotics and fecal microbiota transplantation as corrective measures to improve the human health. Expand
Saturated long-chain fatty acid-producing bacteria contribute to enhanced colonic motility in rats
TLDR
Findings reveal a previously unknown relationship between gut bacteria, intracolonic SLCFAs, and host GI motility, suggesting the importance of SLCFA-producing bacteria inGI motility disorders. Expand
The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions
TLDR
The relationship between the gut and skin microbiome and various dermatological diseases including acne, psoriasis, rosacea, and atopic dermatitis is discussed. Expand
...
1
2
...

References

SHOWING 1-10 OF 65 REFERENCES
Intestinal microbiota in functional bowel disorders: a Rome foundation report
TLDR
A critical review of current hypotheses regarding the pathogenetic involvement of microbiota in FGID is provided and the results of microbiota-directed interventions are evaluated and clinical guidance on modulation of gut microbiota in IBS is provided. Expand
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options
TLDR
The bacterial profile shows that dominant and minor phyla are present in the gastrointestinal tract, and from the proximal to the distal segments of the gut the bacterial density gradually increases, reaching an estimated 1011 to 1012 bacteria per gram of colonic content. Expand
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.
TLDR
The role of the healthy intestinal epithelium as a barrier between the lumen and the rest of the body with a focus on tight junctions is summarized to explore how this increased permeability may elicit immune responses that affect afferent nerves, resulting in the pain associated with IBS. Expand
Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena?
TLDR
This review describes pathways (mechanisms) by which diet components, via the microbial fermentation, could trigger IBS symptoms and suggests recommendations for future studies that would enable elucidation of the role of diet and microbiota and how these factors may be (inter)related in the pathophysiology of IBS. Expand
Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
TLDR
Potential links between the gut microbiota and IBS are highlighted by discussing the current knowledge of the gut bacteria and bacterial-host interactions and how alterations to these interactions could exacerbate, induce or even help alleviate IBS. Expand
Chemotactic Chemokines Are Important in the Pathogenesis of Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is one of the most frequently diagnosed disorders, affecting about 20% of the general population in Western countries. This syndrome poses an enormous socio-economicExpand
Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive Symptoms
TLDR
A large subset of IBS patients shows gender-dependent mucosal infiltration of immunocytes that correlates with abdominal bloating and dysmotility-like dyspepsia, and provides the rationale for considering immune mechanisms as a pathophysiological component in a subset ofIBS patients. Expand
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
TLDR
Functional and anatomical evidence for abnormal neuroimmune interactions has been found in patients with IBS and the link between immune alterations and severity of gastrointestinal symptoms and the positive effect of anti-inflammatory treatments in IBS further highlight the relevance of neuro immune interactions in this condition. Expand
The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome
TLDR
Whether the nonabsorbed antibiotic rifaximin is more effective than placebo in reducing symptoms in adults with IBS is determined. Expand
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.
TLDR
Prevalence of SIBO in individuals meeting diagnostic criteria for IBS was highest with breath testing, and the prevalence in cases with IBS compared with controls varied according to criteria used to define a positive test. Expand
...
1
2
3
4
5
...